SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer

Authors :: Xiangle Sun
Nirupama Sabnis
Ruhani Ahluwalia
Rebecca Johnson
Andras G. Lacko
Source :: Breast Cancer : Targets and Therapy
Publication Year :: 2017
Publisher :: Dove Medical Press, 2017.
Abstract: Patients with triple-negative breast cancer (TNBC) have a considerably less favorable prognosis than those with hormone-positive breast cancers. TNBC patients do not respond to current endocrine treatment and have a 5-year survival prognosis of<br />Video abstract

Tools